Movement Alert｜Argenx SE Intraday Rise 3.38% in Regular Trading, Earnings Preview and Bullish Expectations Support Shares

Market Focus10-15

On October 15, Argenx SE rose 3.38% in Regular Trading, trading near $851.02, with turnover of $58.57 million.

The move aligns with growing market focus ahead of the company’s next earnings release on October 22, as investors look for continued sales momentum from Vyvgart and operating leverage, while overall institutional sentiment has remained constructive.

Market expectations indicate quarterly revenue could increase 58.46% year over year, with expected EPS of $7.44. In the prior quarter, Argenx SE reported revenue of $1.541 billion, up 59.33% year over year, net profit of $472 million, and adjusted EPS of $7.33. After the earlier discontinuation of the phase 3 Sjogren’s disease study, sentiment has partly recovered, and the approaching earnings report appears to be providing near-term support for the stock.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment